StockWatch
·
HomeLiveWeekly

ADC Therapeutics SA

Ticker: 1771910

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-74.60-22.7529.0980.94Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026
PeriodQ1 FY2026Q3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024
INCOME
Revenue20.03+27.2%15.75-12.9%18.09+4.0%17.40-3.4%18.02+5.8%17.03-4.6%17.85
Total Income20.03+27.2%15.75-12.9%18.09+4.0%17.40-3.4%18.02+5.8%17.03-4.6%17.85
EXPENSES
Expenditure46.10-2.7%47.40-24.7%62.99+22.3%51.50-4.7%54.03+16.3%46.45-10.1%51.67
Tax0.000.00-100.0%1.25+635.3%0.17+88.9%0.09-60.9%0.23+43.8%0.16
PROFIT
PBT-32.97+19.5%-40.97+26.0%-55.39-44.1%-38.44+11.9%-43.62-22.2%-35.71+22.0%-45.76
Net Profit-32.97+19.5%-40.97+27.7%-56.65-46.8%-38.60+12.2%-43.97-20.3%-36.54+21.6%-46.61
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.21+30.0%-0.30+40.0%-0.50-38.9%-0.36+14.3%-0.42-10.5%-0.38+32.1%-0.56

Corporate Events

Board MeetingADCT
2026
1Jun

Board Meeting

Annual General Meeting of shareholders to approve financial …

SEC Filing ↗